Arginine ethylester prevents thermal inactivation and aggregation of lysozyme

European Journal of Biochemistry

Volumn 271, Issue 15, 2004, Pages 3242-3247

  Shiraki, Kentaro ^a   Kudou, Motonori ^a   Nishikori, Shingo ^a,b   Kitagawa, Harue ^a,b   Imanaka, Tadayuki ^c   Takagi, Masahiro ^a,b  

^a JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Arginine; Arginine ethylester; Lysozyme; Protein aggregation; Thermal inactivation

Indexed keywords

ARGININE; ARGININE ETHYLESTER; CARBOXYL GROUP; ESTER DERIVATIVE; GUANIDINE; LYSOZYME; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME BINDING; ENZYME INACTIVATION; ENZYME KINETICS; MELTING POINT; MOLECULAR INTERACTION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; THERMOSTABILITY;

ANIMALS; ARGININE; CALORIMETRY, DIFFERENTIAL SCANNING; CHICKENS; CIRCULAR DICHROISM; ELECTROSTATICS; ENZYME STABILITY; FEMALE; HYDROGEN-ION CONCENTRATION; MURAMIDASE; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN FOLDING; TEMPERATURE;

ANIMALIA;

EID: 3242892938     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2004.04257.x     Document Type: Article

References (36)

1. Chiti, F., Calamai, M., Taddei, N., Stefani, M., Ramponi, G. & Dobson, C.M. (2002) Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc. Natl Acad. Sci. USA 99, 16419-16426.
2. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C.M. & Stefani, M. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511.
3. Dobson, C.M. (2003) Protein folding and misfolding. Nature 426, 884-890.
4. Stefani, M. & Dobson, C.M. (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81, 678-699.
5. Fink, A.L. (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold. Des. 3, 9-23.
6. Kopito, R.R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524-530.
7. Tsumoto, K., Ejima, D., Kumagai, I. & Arakawa, T. (2003) Practical considerations in refolding proteins from inclusion bodies. Protein Expr. Purif. 28, 1-8.
8. Kiefhaber, T., Rudolph, R., Kohler, H.H. & Buchner, J. (1991) Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Biotechnology 9, 825-829.
9. Wetlaufer, D.B. & Saxena, V.P. (1970) Formation of three-dimensional structure in proteins. I. Rapid nonenzymic reactivation of reduced lysozyme. Biochemistry 9, 5015-5023.
10. Plaza del Pino, I.M., Ibarra-Molero, B. & Sanchez-Ruiz, J.M. (2000) Lower kinetic limit to protein thermal stability: a proposal regarding protein stability in vivo and its relation with misfolding diseases. Proteins 40, 58-70.
11. Buchner, J. & Rudolph, R. (1991) Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli. Biotechnology 9, 157-162.
12. Rudolph, R. & Lilie, H. (1996) In vitro folding of inclusion body proteins. FASEB J. 10, 49-56.
13. Tsumoto, K., Shinoki, K., Kondo, H., Uchikawa, M., Juji, T. & Kumagai, I. (1998) Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent - application to a human single-chain Fv fragment. J. Immunol. Methods 219, 119-129.
14. Arakawa, T. & Tsumoto, K. (2003) The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem. Biophys. Res. Commun. 304, 148-152.
15. Taneja, S. & Ahmad, F. (1994) Increased thermal stability of proteins in the presence of amino acids. Biochem. J. 303, 147-153.
16. Shiraki, K., Kudou, M., Fujiwara, S., Imanaka, T. & Takagi, M. (2002) Biophysical effect of amino acids on the prevention of protein aggregation. J. Biochem. (Tokyo) 132, 591-595.
17. Sakamoto, R., Nishikori, S. & Shiraki, K. (2004) High temperature increases the refolding yield of reduced lysozyme: Implication for the productive process for folding. Biotechnol. Prog. in press.
18. Kudou, M., Shiraki, K., Fujiwara, S., Imanaka, T. & Takagi, M. (2003) Prevention of thermal inactivation and aggregation of lysozyme by polyamines. Eur. J. Biochem. 270, 4547-4554.
19. Shiraki, K., Kudou, M., Aso, Y. & Takagi, M. (2003) Approach for prevention of heat-induced protein aggregation by small molecular additives. Sci. Technol. Adv. Mat. 4, 55-59.
20. Wetlaufer, D., Kwok, E., Anderson, W.L. & Johnson, E.R. (1974) Kinetic determinism of lysozyme folding at high temperatures. Biochem. Biophys. Res. Commun. 56, 380-405.
21. Babu, K.R. & Bhakuni, V. (1997) Ionic-strength-dependent transition of hen egg-white lysozyme at low pH to a compact state and its aggregation on thermal denaturation. Eur. J. Biochem. 245, 781-789.
22. Volkin, D.B. & Klibanov, A.M. (1987) Thermal destruction processes in proteins involving cystine residues. J. Biol. Chem. 262, 2945-2950.
23. Zale, S.E. & Klibanov, A.M. (1986) Why does ribonuclease irreversibly inactivate at high temperatures? Biochemistry 25, 5432-5444.
24. Tomizawa, H., Yamada, H., Tanigawa, K. & Imoto, T. (1995) Effects of additives on irreversible inactivation of lysozyme at neutral pH and 100 degrees C. J. Biochem. (Tokyo) 117, 369-373.
25. Tomizawa, H., Yamada, H., Wada, K. & Imoto, T. (1995) Stabilization of lysozyme against irreversible inactivation by suppression of chemical reactions. J. Biochem. (Tokyo) 117, 635-640.
26. Kurganov, B.I. (2002) Kinetics of protein aggregation. Quantitative estimation of the chaperone-like activity in test-systems based on suppression of protein aggregation. Biochemistry (Mosc) 67, 409-422.
27. Wang, K. & Kurganov, B.I. (2003) Kinetics of heat- and acid-ification-induced aggregation of firefly luciferase. Biophys. Chem. 106, 97-109.
28. Hook, D.W. & Harding, J.J. (1997) Molecular chaperones protect catalase against thermal stress. Eur. J. Biochem. 247, 380-385.
29. Chang, Z., Primm, T.P., Jakana, J., Lee, I.H., Serysheva, I., Chiu, W., Gilbert, H.F. & Quiocho, F.A. (1996) Mycobacterium tuberculosis 16-kDa antigen (Hsp16.3) functions as an oligomeric structure in vitro to suppress thermal aggregation. J. Biol. Chem. 271, 7218-7223.
30. Smulders, R.H., Merck, K.B., Aendekerk, J., Horwitz, J., Takemoto, L., Slingsby, C., Bloemendal, H. & De Jong, W.W. (1995) The mutation Asp69 → Ser affects the chaperone-like activity of alpha A-crystallin. Eur. J. Biochem. 232, 834-838.
31. Weijers, M., Barneveld, P.A., Cohen Stuart, M.A. & Visschers, R.W. (2003) Heat-induced denaturation and aggregation of ovalbumin at neutral pH described by irreversible first-order kinetics. Protein Sci. 12, 2693-2703.
32. Zettlmeissl, G., Rudolph, R. & Jaenicke, R. (1979) Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation. Biochemistry 18, 5567-5571.
33. Zettlmeissl, G., Rudolph, R. & Jaenicke, R. (1979) Effects of low concentrations of guanidineHCl on the reconstitution of lactic dehydrogenase from pig muscle in vitro. Evidence for guanidine binding to the native enzyme. Eur. J. Biochem. 100, 593-598.
34. Goldberg, M.E., Rudolph, R. & Jaenicke, R. (1991) A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. Biochemistry 30, 2790-2797.
35. Raman, B., Ramakrishna, T. & Rao, C.M. (1996) Refolding of denatured and denatured/reduced lysozyme at high concentrations. J. Biol. Chem. 271, 17067-17072.
36. Chiti, F., Taddei, N., Baroni, F., Capanni, C., Stefani, M., Ramponi, G. & Dobson, C.M. (2002) Kinetic partitioning of protein folding and aggregation. Nat. Struct. Biol. 9, 137-142.